Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.400
0.00 (0.00%)
At close: Mar 12, 2026, 4:00 PM EDT
1.380
-0.020 (-1.43%)
After-hours: Mar 12, 2026, 7:52 PM EDT

Akebia Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
375427427241106400
Market Cap Growth
-5.56%0.03%77.06%127.10%-73.44%-3.52%
Enterprise Value
386.29290.74417.58224.4978.82283.93
Last Close Price
1.401.611.901.240.582.26
PE Ratio
--80.50-5.76-4.43-1.11-1.33
Forward PE
-82.56----
PS Ratio
1.581.812.671.240.361.89
PB Ratio
11.4013.10-8.69-7.8920.315.41
P/TBV Ratio
11.0412.70-8.15-7.6020.175.07
P/FCF Ratio
5.506.31-10.50-10.32-1.45-1.58
P/OCF Ratio
5.486.29-10.51-10.32-1.45-1.58
EV/Sales Ratio
1.641.232.611.150.271.34
EV/EBITDA Ratio
14.1611.74-32.20-26.02-1.83-1.25
EV/EBIT Ratio
14.8612.37-8.27-4.85-0.98-1.07
EV/FCF Ratio
5.714.29-10.26-9.60-1.08-1.12
Debt / Equity Ratio
1.481.48-0.86-0.8512.050.46
Debt / EBITDA Ratio
1.951.95-3.26-5.06-2.21-0.58
Debt / FCF Ratio
0.710.71-1.04-1.87-1.30-0.52
Net Debt / Equity Ratio
-4.19-4.190.20-0.020.87-0.25
Net Debt / EBITDA Ratio
-5.51-5.510.74-0.08-0.110.08
Net Debt / FCF Ratio
-2.02-2.020.24-0.03-0.060.07
Asset Turnover
0.790.790.690.650.660.36
Inventory Turnover
2.482.483.963.982.943.09
Quick Ratio
1.421.421.070.821.010.77
Current Ratio
1.551.551.411.181.431.04
Return on Equity (ROE)
-18.75%64.49%174.03%409.60%-237.83%-175.37%
Return on Assets (ROA)
11.30%11.30%-21.83%-15.48%-18.25%-45.08%
Return on Invested Capital (ROIC)
48.58%48.58%-48.87%-32.10%-39.53%-120.10%
Return on Capital Employed (ROCE)
13.30%13.30%-35.85%-25.12%-32.65%-72.94%
Earnings Yield
-1.44%-1.24%-17.37%-22.58%-90.12%-75.22%
FCF Yield
18.18%15.84%-9.52%-9.69%-68.96%-63.25%
Buyback Yield / Dilution
-16.00%-16.00%-10.07%-2.82%-7.15%-22.24%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q